New ultra-thin light probe enables non-invasive monitoring of brain changes, offering potential for early detection of ...

The Spanish National Cancer Research Centre (CNIO) and the Spanish National Research Council (CSIC) are part of the ...

根据世界卫生组织国际癌症研究机构（IARC）2024年发布的最新评估数据，在2022年，全球癌症新增病例1996万例，全球癌症死亡病例974万例。大约五分之一的男性或女性一生中会患上癌症，而大约九分之一的男性和十二分之一的女性会死于癌症。

Monitoring the changes caused in the brain at the molecular level by cancer and other neurological pathologies in a ...

90%的癌症死亡是由于癌症的扩散，而不是原发肿瘤的并发症。因此，50多年来，科学家们一直在寻找肿瘤内哪些恶性突变允许流氓细胞脱离原发肿瘤，并通过血液和淋巴系统转移到全身。

Monitoring molecular changes in the brain caused by cancer and other neurological pathologies in a non-invasive way is one of ...

Ibrance is under clinical development by Pfizer and currently in Phase III for Metastatic Breast Cancer. According to GlobalData, Phase III drugs for Metastatic Breast Cancer have a 44% phase ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Autonomix received a patent from the U.S. Patent and Trademark Office (USPTO) for its catheter-based cancer tumor treating ...

Breast cancer cells exhibit organotropism during metastasis, showing preferential homing to certain organs such as bone, lung, liver, and brain. One potential explanation for this organotropic ...